|
Pharmacological Group: Anticoagulants, Antagonists And Antiplatelet Agents, Active Ingredient: Tranexamic Acid, Pharmaceutical Form: Tablet, Concentration / Dosage: 250, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Concentration / Dosage: 50, Unit: Mg/Ml, Volume: 5 Ml, Presentation: Ampoule, Pharmacological Group: Non-Steroidal Anti-Inflammatory Agents, Active Ingredient: Ursodeoxycholic Acid, Concentration/Dosage: 150, Pharmacological Group: Pulmonary Surfactant Agents, Active Ingredient: Alfaporactant, Pharmaceutical Form: Injectable Solution, Concentration/Dosage: 80 Mg/ Ml, Volume: 1.5 Ml, Presentation: Fr, Concentration / Dosage: 80 Mg/Ml, Volume: 3 Ml, Presentation: Bottle, Accessory: N/A, Supply Form: Unit, 12/20/2024, Pharmacological Group: Antibacterials, Principle Active: Ampicillin Sodium, Pharmaceutical Form: Powder For Injectable Solution, Concentration / Dosage: 500, Volume: N/A, Presentation: Ampoule Vial, Active Ingredient: Benzylpenicillin Procaine+Benzylpenicillin Potassium, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration / Dosage: 300,000 + 100,000, Unit: Ui / Ui, Active Ingredient: Phytomenadione (Vitamin K1), Concentration / Dosage: 10, Volume: 1Ml, Pharmacological Group: Antianemics, Active Ingredient: Ferrous Sulfate, Pharmaceutical Form: Oral Solution, Concentration / Dosage: 125, Volume: 30Ml, Presentation: Dropper Bottle
|
